About Alessandra Di Bacco
Form D filings for EvolveImmune Therapeutics Holding Company from 2020 to 2023 list Alessandra Di Bacco as director.
Alessandra Di Bacco first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Alessandra Di Bacco in the role, so the role may have started earlier or lasted longer.
EvolveImmune Therapeutics Holding Company, LLC
Director
2020 – 2023 · Branford, CT
Develops immune-based cancer treatments for patients with solid tumors and blood cancers.
Key Colleagues at Startups
The people Alessandra Di Bacco works with at each company, as listed on that company's latest Form D.
EvolveImmune Therapeutics Holding Company, LLC · Form D, Nov 16, 2023
DP
Denis Patrick
Director
DY
Derek Yoon
Director
IT
Ian Taylor
Director
SB
Stephen Bloch
Co-founder and Chief Executive Officer, director